Exchange: NASDAQ·
News
all
press releases
IGM Biosciences, Inc. (IGMS) Q2 Earnings and Revenues Surpass Estimates
IGM Biosciences (IGMS) delivered earnings and revenue surprises of +626.67% and +4,388.22%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks
More News
IGM Biosciences, Inc. (IGMS) Reports Q1 Loss, Misses Revenue Estimates
Zacks
Orchestra BioMed Holdings, Inc. (OBIO) Reports Q1 Loss, Tops Revenue Estimates
Zacks
Monte Rosa Therapeutics (GLUE) Tops Q1 Earnings and Revenue Estimates
chainwire
Snowflake Stock Jumps Over 21% In Premarket Following Beat-and-Raise Q3: Retail Braces For ‘Parabolic’ Run
Snowflake CEO Sridhar Ramaswamy said, “Our obsessive drive to produce product cohesion and ease of use has built Snowflake into the easiest and most cost effective enterprise data platform.”
Stocktwits

Advertisement|Remove ads.